FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a composition based on stable epoprostenol sodium, which has a vasodilating and inhibitory effect on platelet aggregation, which consists of the sodium salt of epoprostenol and sodium hydroxide in a ratio of 3-7.5 g of sodium hydroxide per 100 g of the sodium salt of epoprostenol, as well as a method for its preparation.
EFFECT: new stable composition based on sodium epoprostenol has been obtained, which can be stored in a low-temperature freezer (-20±5°C) for at least 3 years.
8 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
EPOPROSTENOL-CONTAINING COMPOSITION AND METHOD OF ITS OBTAINING | 2007 |
|
RU2423130C2 |
FLUORINATED ANALOGS OF PROSTACYCLINE HAVING ANTIAGGREGATING EFFECT AND PROCESS FOR PREPARING SAME | 0 |
|
SU947999A1 |
METHOD OF PRODUCING DERIVATIVES OF PROSTAGLANDIN | 0 |
|
SU1274621A3 |
METHOD OF PRODUCING DERIVATIVE OF INTER-M-PHENYLENE-PROSTACYCLINES | 0 |
|
SU1391501A3 |
PROCESS FOR PREPARATION OF LEVOTHYROXINE AND SALTS THEREOF | 2015 |
|
RU2673540C2 |
METHOD OF PREPARING WATER-SOLUBLE CHLORINES | 1998 |
|
RU2144538C1 |
METHOD FOR OBTAINING ILOPROST | 2019 |
|
RU2798239C2 |
PROCESS FOR PREPARING 4-THIA- OR 4-SULFINYL-PGI 1 DERIVATIVES | 0 |
|
SU1053746A3 |
PROSTACYCLIN ANALOGUE PREPARATIONS | 2017 |
|
RU2757903C2 |
ORTHO-SUBSTITUTED BENZOYLGUANIDINES AND MEDICINAL AGENTS CONTAINING THEREOF | 1997 |
|
RU2212400C2 |
Authors
Dates
2021-05-11—Published
2017-03-21—Filed